PALB2 Gene Breast Cancer Susceptibility to Genetic Test
Genetic testing plays a crucial role in identifying the risk factors for various diseases, including breast cancer. DNA Labs UAE offers a comprehensive genetic test for PALB2 gene mutations, which are associated with an increased risk of developing breast cancer.
Test Details
The PALB2 gene, also known as the partner and localizer of BRCA2, is involved in DNA repair and has been linked to an elevated risk of breast cancer. Mutations in the PALB2 gene can lead to an increased susceptibility to breast cancer, similar to mutations in the BRCA1 and BRCA2 genes.
Our PALB2 gene breast cancer susceptibility test utilizes Next-Generation Sequencing (NGS) technology. NGS allows for the simultaneous analysis of multiple genes, including PALB2, in a more efficient and cost-effective manner compared to traditional sequencing methods.
The test requires a blood sample or extracted DNA, or even just one drop of blood on an FTA card. The sample condition is essential for accurate results. The test report is delivered within 3 to 4 weeks.
Importance of Genetic Testing
Genetic testing for PALB2 gene mutations can provide valuable information about an individual’s susceptibility to breast cancer. By sequencing the PALB2 gene, we can identify any mutations or variations that may be present.
It is important to note that a positive result for a PALB2 gene mutation does not guarantee that an individual will develop breast cancer. However, it does indicate an increased risk compared to the general population. This information can guide healthcare providers in developing personalized screening and prevention strategies.
Pre-Test Information
Prior to undergoing the PALB2 gene breast cancer susceptibility test, it is essential to provide the clinical history of the patient. This includes any relevant information about the patient’s family members who have been affected by PALB2 gene breast cancer.
Our genetic counseling session includes drawing a pedigree chart to understand the familial patterns of breast cancer and identify potential risk factors.
Test Cost and Doctor
The cost of the PALB2 gene breast cancer susceptibility test is AED 4400.0. The test is performed by an oncologist in our Genetics department.
Consultation and Testing Options
It is important to consult with a healthcare provider or genetic counselor to determine the appropriate testing options. Not all genetic testing laboratories include PALB2 in their standard panel of genes analyzed.
DNA Labs UAE is dedicated to providing accurate and reliable genetic testing services. Contact us today to schedule a consultation and learn more about your risk of developing breast cancer.
| Test Name | PALB2 Gene Breast cancer susceptibility to Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PALB2 Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PALB2 Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene PALB2 |
| Test Details |
The PALB2 gene (partner and localizer of BRCA2) is a gene that plays a role in DNA repair and is associated with an increased risk of breast cancer. Mutations in the PALB2 gene can lead to an increased risk of developing breast cancer, similar to mutations in the BRCA1 and BRCA2 genes. NGS (Next-Generation Sequencing) is a genetic testing method that can be used to identify mutations in the PALB2 gene. NGS allows for the simultaneous analysis of multiple genes, including PALB2, in a more efficient and cost-effective manner compared to traditional sequencing methods. A NGS genetic test for PALB2 gene mutations can be performed to determine an individual’s susceptibility to breast cancer. This test involves sequencing the PALB2 gene to identify any mutations or variations that may be present. The results of the test can help inform individuals about their risk of developing breast cancer and guide healthcare providers in developing personalized screening and prevention strategies. It is important to note that a positive result for a PALB2 gene mutation does not guarantee that an individual will develop breast cancer, but it does indicate an increased risk compared to the general population. Additionally, not all genetic testing laboratories may include PALB2 in their standard panel of genes analyzed, so it is important to consult with a healthcare provider or genetic counselor to determine the appropriate testing options. |
